Use of hepatitis B vaccination for adults with diabetes mellitus: Recommendations of the advisory committee on immunization practices (ACIP)

Morbidity and Mortality Weekly Report

Volumn 60, Issue 50, 2011, Pages 1709-1711

  Sawyer, Mark H ^a   Hoerger, Thomas J ^b   Murphy, Trudy V ^c   Schillie, Sarah F ^c   Hu, Dale ^c   Spradling, Philip R ^c   Byrd, Kathy K ^c   Xing, Jian ^c   Reilly, Meredith L ^c   Tohme, Rania A ^c   Moorman, Anne ^c   Smith, Emily A ^c   Baack, Brittney N ^c   Jiles, Ruth B ^c   Klevens, Monina ^c   Ward, John W ^c   Kahn, Henry S ^d   Zhou, Fangjun ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RTI INTERNATIONAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ADVISORY COMMITTEE; AGED; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEPATITIS B; HUMAN; INFECTION CONTROL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; RISK; STANDARD; UNITED STATES;

ADULT; ADVISORY COMMITTEES; AGED; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; RISK; UNITED STATES; YOUNG ADULT;

EID: 84255162321     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Thompson ND, Perz JF. Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol 2009;3:283-8.
2. Reilly ML, Poissant T, Vonderwahl CW, Gerard K, Murphy TV. Incidence of acute hepatitis B among adults with and without diabetes, 2009-2010. Presented at the 49th Annual Meeting of the Infectious Disease Society of America and the HIV Medicine Association; Boston, MA, October 20-23, 2011.
3. CDC. Viral hepatitis surveillance-United States, 2009. Atlanta, GA: US Department of Health and Human Services; 2011. Available at http://www.cdc.gov/hepatitis/statistics/2009surveillance/index.htm. Accessed December 15, 2011.
4. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995;20:992-1000.
5. CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR 2006;55(No. RR-16).
6. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-8.
7. Klonoff DC, Perz JF. Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Science Technol 2010;4:1027-31.
8. CDC. Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities-Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR 2005;54:220-3.
9. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011;53:68-75.
10. Yao X, Hamilton RG, Weng NP, et al. Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine 2011;29:5015-21.